Press Releases

and/or
558 News Releases found
Fred's Team runners smile at supporters during the 2025 TCS New York City Marathon. 100% of the money raised through Fred's Team goes directly to cancer research at Memorial Sloan Kettering Cancer Center. (Photo credit Ben Solomon for Fred's Team)
Fred's Team Sets Historic $10 Million Fundraising Record for Cancer Research During Its 30th Season
Official running program of Memorial Sloan Kettering Cancer Center sets new single-year fundraising record with every dollar raised going directly to cancer research.
Whitney Snider, MD, MBA, joins Memorial Sloan Kettering Cancer Center as the inaugural Managing Partner of MSK Ventures
Whitney Snider, MD, MBA, joins Memorial Sloan Kettering Cancer Center as the inaugural Managing Partner of MSK Ventures
Memorial Sloan Kettering Cancer Center (MSK) has welcomed Whitney Snider, MD, MBA, as the inaugural Managing Partner of MSK Ventures – a dedicated investment pool that will raise and direct funds to high-growth, early-stage startups created and/or nurtured by MSK faculty and staff.
MSK Awards and Appointments December 2025
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Jason Lewis Elected as a Fellow of the National Acad...
Deb Schrag
Deb Schrag, MD, MPH, Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center, Named President of the American Society of Clinical Oncology
Deb Schrag, MD, MPH, FASCO, gastrointestinal medical oncologist and George J. Bosl Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK), has been elected 2027-28 President of the American Society of Clinical Oncology (ASCO), the world's leading professional organization for physicians and oncology professionals caring for people with cancer.
Cycle for Survival Kicks Off the 2026 Season, Celebrates 20 Years of Impact, and Welcomes NoBull as Apparel Partner
Cycle for Survival Kicks Off the 2026 Season, Celebrates 20 Years of Impact, and Welcomes NOBULL as Apparel Partner
Official rare cancer fundraising program of Memorial Sloan Kettering Cancer Center to host its stationary-cycling events in 16 locations nationwide. Instructors from Equinox, Cycle for Survival’s founding partner, will lead the high-energy rides.
Jason Lewis
Memorial Sloan Kettering Cancer Center Radiochemist, Jason Lewis, PhD, Elected to the National Academy of Inventors
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Jason Lewis, PhD, has been elected as a Fellow of the National Academy of Inventors (NAI), a prestigious honor recognizing individuals who have demonstrated innovation and made tangible contributions to the advancement of technology and society.
Lorenzo Falchi
Study Led by Memorial Sloan Kettering Investigators Shows Three-Agent Combination Demonstrates Promising Efficacy for Relapsed Follicular Lymphoma
Researchers from Memorial Sloan Kettering Cancer Center (MSK) announced today that the latest results from that follicular lymphoma clinical trial have shown the three-drug combination — rituximab (Rituxan®) and lenalidomide (Revlimid®), along with epcoritamab (Epkinly®) — works better than using the two drugs alone. The findings were presented at the American Society of Hematology Annual Meeting (ASH) on December 7, 2025. The findings were also published in The Lancet.
MSK Awards and Appointments October and November 2025
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Omar Abdel-Wahab Elected to the National Academy of ...
Memorial Sloan Kettering Cancer Center Issues Statement on Third Quarter 2025 Financial Results
Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first three quarters of 2025:
Paul Marks Prize
Three Investigators Named Winners of Memorial Sloan Kettering Cancer Center’s 2025 Paul Marks Prize for Cancer Research
Memorial Sloan Kettering Cancer Center (MSK) will award three influential cancer researchers with this year’s Paul Marks Prize for Cancer Research. The prize, named in honor of former MSK president Paul Marks, MD, recognizes a new generation of leaders who are making significant contributions to the understanding of cancer or are improving the treatment of the disease.